Diseases caused by altered specificity of a protein kinase for its allosteric activators

被引:0
|
作者
Cohen, Philip [1 ]
Snelling, Tom [1 ]
机构
[1] Univ Dundee, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee, Scotland
基金
英国惠康基金; 英国医学研究理事会;
关键词
NF-KAPPA-B; DEPENDENT KINASE; DISCOVERY; HEPTOSES; BINDING;
D O I
10.1016/j.tibs.2024.10.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein kinases regulate many intracellular processes, and their dysregulation causes cancers and other diseases. This review focuses on the atypical alpha-kinase 1 (ALPK1), which is activated in mammalian cells by nucleoside diphosphate heptoses (ADP-heptose, UDP-heptose, and CDP-heptose) produced by microbial pathogens but not by mammalian cells. Mutations in human ALPK1 cause ROSAH syndrome and spiradenoma, which result from an alteration in its specificity for nucleoside diphosphate heptoses, causing aberrant activation by mammalian nucleoside diphosphate sugars without microbial infection. These may be the first diseases caused by altered specificity of an enzyme for its allosteric activators and has suggested ways in which selective drugs could be developed to treat them without compromising the innate immune system.
引用
收藏
页码:61 / 70
页数:10
相关论文
共 50 条
  • [21] The Kinase Specificity of Protein Kinase Inhibitor Peptide
    Chen, Yao
    Sabatini, Bernardo L.
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [22] Competitive inhibitors and allosteric activators of protein kinase C isoenzymes: a personal account and progress report on transferring academic discoveries to the clinic
    Budas, G. R.
    Koyanagi, T.
    Churchill, E. N.
    Mochly-Rosen, D.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 : 1021 - 1026
  • [23] Allosteric modulation of a human protein kinase with monobodies
    Zorba, Adelajda
    Nguyen, Vy
    Koide, Akiko
    Hoemberger, Marc
    Zheng, Yuejiao
    Kutter, Steffen
    Kim, Chansik
    Koide, Shohei
    Kern, Dorothee
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (28) : 13937 - 13942
  • [24] Thermodynamic Basis of the Allosteric Acitvation of Protein Kinase A
    Kim, Jonggul
    Chao, Frank
    Veglia, Gianluigi
    BIOPHYSICAL JOURNAL, 2014, 106 (02) : 649A - 649A
  • [25] Protein Kinase C Activators as Synaptogenic and Memory Therapeutics
    Sun, Miao-Kun
    Alkon, Daniel L.
    ARCHIV DER PHARMAZIE, 2009, 342 (12) : 689 - 698
  • [26] Neuroprotective versus tumorigenic protein kinase C activators
    Nelson, T. J.
    Alkon, D. L.
    TRENDS IN BIOCHEMICAL SCIENCES, 2009, 34 (03) : 136 - 145
  • [27] DIOL LIPIDS ARE ACTIVATORS OF PROTEIN KINASE-C
    SEVERIN, SE
    TOVMASYAN, EK
    SHVETS, VI
    MOLOTKOVSKY, JG
    BERGELSON, LD
    FEBS LETTERS, 1988, 232 (02) : 286 - 288
  • [28] Activators of protein kinase A and oxytocin affect rabbit reproduction
    Balazi, Andrej
    Sirotkin, Alexander V.
    Chrenek, Peter
    CENTRAL EUROPEAN JOURNAL OF BIOLOGY, 2012, 7 (06): : 973 - 979
  • [29] Novel Quinolinones as Activators of AMP Activated Protein Kinase
    Rosse, Gerard
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (11): : 884 - 885
  • [30] DIOL LIPIDS, ACTIVATORS OF PROTEIN KINASE-C
    SEVERIN, SE
    TOVMASYAN, EK
    SHVETS, VI
    MOLOTKOVSKY, YG
    BERGELSON, LD
    BIOLOGICHESKIE MEMBRANY, 1987, 4 (12): : 1335 - 1336